proper and the glomus jugulare tympanicus tumor (7) . The staging proposed by Alford and Guilford (8) embodied this dichotomy, with the tympanicum confined to the middle ear and the jugulare involving the jugular bulb and the skull base. Other classifications have been used (9) , but this basic distinction is still recognized today (10) .
Glomus Tumors as Paragangliomas
Glomus tumors are paragangliomas, which are tumors of neural crest origin outside the adrenal medulla, and are capable of secreting catecholamines in autonomic ganglia, the organ of Zuckerkandl, or adjacent to ganglia (11) . Paragangliomas originate in the head and neck from the brachiomeric family of paraganglia, neuroendocrine tissue that lies along the carotid artery, the aorta, the glossopharyngeal nerve, and the middle ear (3). Glomus tumors are not the most common paragangliomas. Indeed, almost all paragangliomas arise from the carotid body (12, 13) . Glomus tumors can coexist with other paragangliomas, most commonly those arising in aortic or carotid bodies. When a glomus tumor arises, there is a 10%-25% chance of a second craniocervical paraganglioma, usually a carotid body tumor (14) .
dysfunction. Pulsatile tinnitus, conductive hearing loss, aural fullness, discharge or bleeding, and a bluishred mass behind the tympanic membrane are characteristic of the former. Facial paralysis, dysphonia, marked hearing loss, and pain typify the latter (17) . Neurologic symptoms usually begin after aural symptoms (20) .
Treatment Options
The controversy concerning surgical versus radiation treatment continues. With small lesions, radiation is advocated (21) (22) (23) (24) . With younger patients and tumors causing bony destruction, surgery is recommended (1 0, 25) . The risk of recurrence is present but the chance for definitive cure along with long-term compensation for cranial nerve deficits have made the surgical option increasingly attractive (26, 27) . Nonoperative treatment is considered appropriate in many cases due to the benign course and the extensive nature of surgery at the skull base, with its considerable risks (17). Support for conservative care comes from a report of a 40-yr history before therapy (20) and a relatively low rate of recurrence after radiation treatment (15) .
Diagnosis
Diagnostic evaluation after a suggestive otologic examination has four major goals: to determine the size and extent of the disease, including intracranial extension; to detect associated lesions; to define collateral circulation; and to assess major vasculature (5). These determinations currently rely upon several modalities, including computed tomography (CT) and threedimensional computed tomography (3D-CT), magnetic resonance imaging, angiography, and magnetic resonance angiography. High resolution, contrast enhanced, CT best shows the extent of disease and possible tumor erosion of the skull base. It is especially useful in the differentiation of glomus tympanicum from glomus jugulare tumors. Magnetic resonance imaging demonstrates tumor vascularity and threedimensional relationships of the tumor to surrounding vascular structures. Gadolinium-enhanced magnetic resonance imaging is useful for the detection of small tumors of the middle ear (28) . Angiography reveals the vascular extent of the tumor, jugular vein patency, and carotid artery involvement, with bilateral evaluation of the carotid bifurcation indicated (29, 301 . Magnetic resonance angiography is sometimes useful in predicting the need for temporary cross-clamp, or even permanent sacrifice, of the internal carotid artery. Jugular vein phlebography can detect finger-like tumor projections that may extend to the heart or embolize at the time of excision (31) , but this technique has become virtually obsolete with the advent and effectiveness of 3D-CT for tumor mapping and surgical planning (32) . Radionucleotide scintigraphy can provide additional functional information (33) . Whatever imaging techniques are used, the risks of recurrence make radiographic follow-up necessary (34) .
Anesthetic Risk
Anesthetic management in patients with glomus tumors is a formidable challenge. This relates to the following important risks associated with their resection:
Catecholamine Secretion Producing Symptoms of a Pheockromocytoma
The relationship between glomic and true chromaffin tissue has been noted. Suspicions regarding catecholamine secretion were raised when Berdal(351, Huppler et al. (36) , and Rossenwasser (7) noted intraoperative blood pressure elevations with the surgical manipulation of some glomus tumors. Duke et al. (37) first reported that glomus tumors can independently secrete large amounts of norepinephrine, and can present clinically in the same way as a pheochromocytoma. This is not surprising given their relationship to neuroectodermal and chromaffin tissue but it is rare; only 1 %-4% of glomus tumors mimic a pheochromocytoma (38, 391 . Catecholamine levels of three to five times normal are required to produce clinical symptoms, and glomus tumors may secrete amounts several times normal and be subclinical (38) .
Serotonin Secretion Producing a Carcinoid-Like Syndrome
The endocrine capability of glomus tumors is not restricted to catecholamine secretion. It also includes the release of 5-hydroxytryptamine (serotonin), kallikrein, and 5-hydro~ytryptophan~ a precursor of serotonin and histamine. Although several cases of carcinoid syndrome have been associated with carotid body tumors (40, 41) , carcinoid syndrome caused by glomus tumors was not reported until 1980 (42) .
Carcinoid tumors most often originate in the small intestine but can arise from any organ system (43) . A consistent history includes bronchoconstriction, tricuspid regurgitation and/or pulmonic stenosis, abdominal pain and explosive diarrhea resulting in dehydration and electrolyte abnormalities, violent headaches, cutaneous flushing, and hypertension, hepatomegaly, and hyperglycemia (42,441. Intraoperatively, histamine and bradykinin released during surgical manipulation can cause profound hypotension and even shock (43) . Interestingly, bronchoconstriction in this setting is often not responsive to conventional therapy, such as with corticosteroids. Catecholamines may exacerbate the problem by provoking the release of serotonin and kallikreins (44). However, inhaled p-agonists counteract the bronchoconstricting effects of histamine, bradykinin, or serotonin, and are likely to be the most effective therapy. Alternatives would be inhaled anticholinergics, such as ipratropium bromide (Atrovent), because both histamine and bradykinin induce bronchoconstriction in response to the stimulation of afferent cholinergic pathways (with the subsequent release of acetylcholine causing bronchoconstriction) (45) .
The rationale for these choices merits brief review and discussion. Histamine stimulates afferent nerve fibers and subsequent reflex bronchoconstriction through cholinergic mechanisms. In addition, histamine induces bronchospasm by directly stimulating HI-receptors on airway smooth muscle. Bradykmin has not been shown to directly stimulate airway smooth muscle but when bradykinin is inhaled bronchoconstriction results. The bronchoconstriction is likely mediated through cholinergic reflex pathways. The rationale for using anticholinergics for either histamine or bradykinin-induced bronchoconstriction is to block a reflex-induced cholinergic discharge that would cause bronchoconstriction. However, both histamine and bradylunin also cause the release of bronchoconstricting neuropeptides through local axon reflex loops. These are not inhibited by anticholinergics. Inhaled P-agonists are preferable because they block both of these pathways. Serotonin acts like bradykinin and histamine in that it, too, causes bronchoconstriction through the stimulation of afferent nerve fibers and cholinergic pathways. The bronchoconstrictive effects of serotonin, too, are either attenuated or abolished by p-agonists (45,46) (T.B. Casale, personal communication, 1993).
Aspiration or Airway Obstruction After Tumor Resection
Cranial nerve deficits can manifest at the time of presentation or occur after tumor resection. Preoperatively, the vagus nerve is affected most commonly, with the glossopharyngeal and hypoglossal nerves also at risk. Intraoperative sacrifice of cranial nerves is necessary in many cases involving resection of lesions of the jugular fossa. The vagus nerve fares most poorly with glomus vagal tumors and meningiomas, but even with glomus jugulare tumors it is only preserved about half of the time (47) .
Sacrifice of cranial nerve IX, X, XI, or XI1 is well tolerated both acutely and over the long term, but impaired sensory and motor function, especially of the vagus, increases the risk of postoperative aspiration (141, which may occur in nearly 25% of patients (38) . Aspiration in this setting is a consequence of both loss of airway tone and of sensation. The risk of airway obstruction after cranial nerve injury is less than the risk of aspiration, but is real nonetheless. Unilateral cord paralysis, which in an adult usually does not result in complete airway obstruction, certainly can produce obstruction when combined with airway edema or laryngeal distortion.
Primary thyroplasty and vocal cord medialization procedures (medialization laryngoplasty with silastic) are specifically indicated either in the event or anticipation of tenth nerve deficit. They medialize the paralyzed vocal fold so that the normal vocal fold can meet it in the midline. This narrows the airway somewhat by changing the position of the paralyzed vocal fold from a paramedian or lateral position to a median one, but it can help avoid the need for a tracheostomy while improving glottic competence thereby improving coughing, swallowing, and speech (47) . At present, however, tracheostomy is not performed routinely instead of vocal cord medialization, regardless of approach (38, 48, 49) .
Tracheostomy currently is used very seldom for glomus tumor surgery, and usually only for infratemporal fossa surgery involving very large lesions (38, 49) . Tracheostomy does not prevent aspiration, but it does ensure airway patency and, in the event of aspiration, facilitates airway suctioning and care. In addition, it isolates the airway from the skull base. If a patient with a communication between the nose and the brain coughs (even if the communication is small) a pneumocephalus can result. With a cuffed endotracheal tube, aspiration can be controlled quite effectively (C. G. Jackson, personal communication, 1993) . Low pressure, high compliance cuffs and frequent external monitoring and control of cuff pressure minimize ischemia of the tracheal wall (50) (51) (52) (53) .
Impaired Gastric Emptying
Cranial nerve integrity and airway competence are especially important in view of the recent suggestion that, after glomus tumor removal patients may be at increased risk for postoperative ileus on the basis of elevated cholecystokinin (CCK) levels. Slowed gastrointestinal motility in patients with partial airway compromise on the basis of cranial nerve injury, especially to the vagus nerve, obviously places them at risk for the aspiration of gastric contents postoperatively. Jackson et al. (54) observed that the perioperative management of patients undergoing surgical resection of a glomus tumor is associated with gastrointestinal complications such as pancreatitis, cholecystitis, and ileus far exceeding what would be expected. In terms of postoperative ileus, they postulate that a decrease in CCK (which they found to be approximately twice as great in these patients compared to patients with nonglomus skull base tumors) may be causative: "Elevation of serum gastrin levels is followed by an increase in specific receptors on target cells. If the same holds true for CCK receptors, a reduction in serum CCK to "normal" levels would result in a reduced receptor occupation and (possibly) failure of gastric emptying, diminished pancreatic secretory activity, and lack of gallbladder contraction" (54) . To minimize the potentially significant risk of postoperative aspiration, prudent postoperative care may entail not only nasogastric suction but also a period of parenteral nutrition.
In creased In t racran ial Pressure
Although intracranial extension of these tumors is usually extradural and confined to the posterior fossa, they can extend to the middle fossa. Significant intracranial hypertension with glomus tumors is rare. When it occurs, it is usually due to tumor occlusion of venous sinuses. In the past, the sitting position was frequently used to facilitate exposure. The lateral position is used most frequently today to decrease the risk of venous air embolism.
Threat of Venous Air Embolism
Venous air embolism is a risk during many types of surgery (55) (56) (57) (58) (59) (60) (61) (62) (63) . Air embolism has been reported in craniofacial procedures (64) and head and neck trauma (65) but the risk during resection of glomus tumors has not been quantified. This risk is probably heightened with involvement of the jugular vein or the need to open the sigmoid sinus, a common surgical maneuver, given the propensity of the tumor for extension (66). Proximal and distal ligation of the vein and packing of the wound before tumor manipulation or resection is mandatory in order to diminish the risk of air embolism. Lateral positioning intraoperatively is most appropriate, the sitting position being unnecessary and even contraindicated (C. G. Jackson, personal communication, 1993).
Substantial Blood Loss
The resection of these highly vascular lesions can be associated with substantial blood loss. Blood replacement in one report averaged 3-8 units and the length of operation ranged from 8-26 h (38) . The sigmoid sinus, the inferior petrosal sinus, and the tumor itself are the major sources of bleeding (47) . In one patient in one series, 5000 mL of blood was lost in 1 h (1). In another patient, up to 14 units of blood were transfused (67). Massive blood loss is of particular concern with intracranial extension requiring opening of the sigmoid sinus or intrajugular extension.
Preoperative embolization diminishes intraoperative blood loss and shortens operative time (68,691. Despite these advantages, many surgeons choose not to embolize these tumors because of the risk of associated morbidity: vascular injury, stroke, death (70). Other strategies to combat significant blood loss during surgery include external carotid and jugular vein ligation and hypotensive anesthesia (71).
Anesthetic Management
Anesthetic management stems directly from preoperative concerns. One of the most important involves excess catecholamine or serotonin secretion. Both, especially catecholamine secretion, can be life-threatening. A careful history and physical examination are crucial in addressing this issue. Suggestive symptoms include severe hypertension, sweating, myocardial infarction, and cardiovascular collapse for catecholamine excess (11, 721 The problem with this latter strategy is that undiagnosed pheochromocytomas lead to high perioperative morbidity and mortality (74-76). Although there are fewer reports of undiagnosed catecholaminesecreting glomus tumors, there is every reason to believe that perioperative morbidity would be high without proper preoperative preparation and, just as with pheochromocytomas, would sharply diminish with proper preoperative pharmacologic preparation (77) . Further, Jackson, who routinely tests serum catecholamines in patients with glomus tumors, regardless of the history and physical examination, has found catecholamine levels as high as eight times normal without clinical symptoms (C. G. Jackson, personal communication, 1993). This suggests the need to preoperatively check serum catecholamine levels in all patients with suspected glomus tumors. The cost for this is $96.00 at our institution but, given the potential perioperative morbidity of an undiscovered catecholamine-secreting glomus tumor, the additional expense would seem justified. The biochemical diagnosis of catecholaminesecreting tumors has been outlined elsewhere (77) . In terms of serotonin-secreting tumors, the number of reported cases is fewer, and although the morbidity can be significant, the chance of occurrence is very small. Therefore, a routine plasma serotonin level in the absence of clinical symptoms is probably unnecessary.
Significant elevations of urine or serum catecholamines or their metabolites require the same preoperative pharmacologic stabilization in these head and neck tumors as for a pheochromocytoma. There are several drugs and protocols for treatment. The most traditional rely upon a-and P-adrenergic block. One recommended regimen involves phenoxybenzamine I to 2 wk before elective surgery, starting with an initial dose of 10 mg twice a day and gradually increasing to final doses of 40-100 mg/day. Phenoxybenzamine blocks both postsynaptic a,-receptors and presynaptic a*-receptors, the latter leading to enhanced catecholamine secretion and possible tachycardia. Prazosin, a selective a,-antagonist, causes less tachycardia than phenoxybenzamine. It also is shorter acting, resulting in less prolonged postoperative hypotension. Usual initial doses are 1 mg three times a day with final daily doses of 8-12 mg. Labetalol, a combined a-and P-blocking drug, has been used successfully in the preoperative preparation of pheochromocytoma. P-Adrenergic block is not required in most cases, but if used, these drugs should never be started before the institution of a-block. Unopposed a-agonism in the setting of P-block can lead to severe vasoconstriction and hypertensive crisis and, because the P-blocked heart may not be able to compensate for the increased systemic vascular resistance, myocardial ischemia, infarction, and failure can occur (60, 61) . Recently, other therapies have been suggested for the preoperative preparation of patients with pheochromocytoma. Two examples are calcium channel block and magnesium sulfate. Nicardipine, used orally in the preoperative period (60-120 mg/24 h), and intravenously intraoperatively, 2.5-7.5 pg.kg-'.min-' by infusion, has been used successfully to control pheochromocytomas (78) . Magnesium sulfate in combination with fentanyl also has been used successfully as an adrenergic antagonist intraoperatively at a dose of 40-60 mg/kg intravenously followed by a continuous infusion of 1-2 gm/h. In some such cases, sodium nitroprusside may be necessary to control hypertension (79) .
Serotonin-secreting glomus tumors should be identified, if at all possible, by clinical history preoperatively. Dehydration or electrolyte abnormalities should be corrected. Somatostatin inhibits the release of serotonin, but it has a very short plasma half-life. Octreotide (Sandostatin, Sandoz), a long-acting somatostatin analog with no major side effects, decreases the storage and release of mediators in the perioperative period and a regimen consisting of 100 1-18 subcutaneously, two to three times daily, should be started 2 wk before surgery in symptomatic patients (80) . Intraoperatively, histamine and bradykinin released during surgical manipulation can cause bronchospasm, decreased pulmonary compliance, profound hypotension, and even shock. Therapy must be centered on either blocking the release of chemical modulators or blocking their actions. Again, octreotide is useful, with 100 1-18 intravenously at induction recommended (81) . Severe hypertension is of particular concern. 5-Hydroxytryptamine may increase vascular response to catecholamines by stimulating the release and inhibiting the uptake of noradrenaline and potentiating postjunctional aladrenoceptor mediated response to both epinephrine and norepinephrine (82). Ketanserin, a selective antagonist at 5-HT2-receptors, a,-adrenoceptors, and HIhistamine receptors, may offer the best pharmacologic profile to treat a hypertensive carcinoid-like crisis. An infusion of 5 mg/h is suggested (80, 83) . Postoperatively, octreotide should be continued for 72 h and slowly discontinued over several days.
Involvement of cranial nerves that may predispose to airway obstruction or aspiration may occur in one of several ways: tumor invasion preoperatively, nerve injury or sacrifice intraoperatively, or tissue edema causing nerve palsy postoperatively. Whatever the mechanism, ninth, tenth, or twelfth cranial nerve dysfunction can predispose to airway compromise, either by aspiration or obstruction. Preoperatively, a careful history and physical examination focused upon the potential problem of airway compromise is required. If the patient has had previous head and neck surgery, an assessment of vocal cord function and position is important. Intraoperatively, the anesthesiologist should be aware of nerve sacrifice or inadvertent nerve damage. Postoperatively, the dynamic nature of edema around cranial nerves 1 to 3 days after the procedure must be appreciated by both the anesthesiologist, surgeon, and nursing staff. Frequent observation for stridor and wheezing is key.
The risk of aspiration caused by gastroparesis is increased in these patients. The findings of Jackson et al. (54) suggest heightened awareness and caution, conservative airway management including a tracheostomy or endotracheal tube, intermittent nasogastric suction, and postoperative total parenteral nutrition.
The possibility of intracranial hypertension must be considered. Although rare in these cases, it can be lifethreatening. Suggestive signs and symptoms should be elicited and the CT scan evaluated for intracranial extension. Elevation in intracranial pressure may be related to obstructive hydrocephalus with ventricular enlargement or to the mass effect of the tumor.
Anesthetic management in the setting of intracranial hypertension secondary to tumor extension should follow the same general principles as for other intracranial mass lesions (84, 85) . In general, sedative premedication should be avoided. The relationship of mean arterial pressure to cerebral perfusion pressure emphasizes the importance of an intraarterial catheter. Induction and maintenance of anesthesia should be tailored to avoid an exacerbation of elevated intracranial pressure. Although there are many methods to achieve this, one includes spontaneous hyperventilation, thiopental to achieve narcosis, and mask hyperventilation followed by neuromuscular relaxation with a long-acting nondepolarizer. The slow administration of fentanyl or sufentanil, laryngotracheal lidocaine followed by an assessment of mean arterial pressure, and volatile anesthetics by mask (if necessary) are important adjuncts to control a hyperdynamic response to laryngoscopy. With intubation achieved and hyperventilation established (Pacop 25-30 mm Hg), volatile anesthetics in moderate doses can be used with safety. The administration of mannitol and placement of a lumbar subarachnoid catheter for withdrawal of cerebrospinal fluid are other useful adjuncts in controlling intracranial pressure. Avoidance of dextrose-containing intravenous solutions is recommended (86-88).
It is important to appreciate the risk of massive blood loss. Besides the standard monitors, an arterial line, Foley catheter, and central venous pressure monitor (or a pulmonary artery catheter) are suggested. Substantial blood loss can occur rapidly and require transfusion. Volume status should be monitored with a central venous pressure monitor and replaced through a large-bore intravenous catheter. Before placement of a central line, tumor involvement of both the internal jugular vein and the superior vena cava should be assessed. If the internal jugular vein, but not the superior vena cava, has been invaded by tumor, the contralateral basilic, external or internal jugular vein can be used to gain central access. If both have been invaded, the femoral vein should be used. The importance of central placement mandates chest radiography or fluoroscopy when a basilic vein is used, given the tendency for the catheter tip to progress to a noncentral location, usually in the neck (1). Two large, peripheral intravenous lines should be placed. Blood salvage for transfusion, in the presence of tumor, is not usually done, but controlled hypotension with deep inhalation anesthesia and sodium nitroprusside may be useful to decrease blood loss (89) (90) (91) (92) .
Air or tumor embolism is extremely rare in these cases, partly because the patient is usually placed in a supine or lateral position with the head secured by either a Mayfield skull clamp or horseshoe head rest (C. G. Jackson, personal communication, 1993) . With invasion of the internal jugular vein, tumor embolism is nevertheless a risk. This may explain several sudden deaths and emphasizes the importance of early proximal and distal vein ligation, and even cardiopulmonary bypass, in such cases (31, 931 . With proximal and distal vein ligation before tumor resection, the risk of air or tumor embolism is greatly diminished (C. G. Jackson, personal communication, 1993).
If the carotid artery is to be occluded intraoperatively, some form of assessing the adequacy of cerebral perfusion may be warranted. This may include electroencephalogram, somatosensory evoked responses, arterial stump pressure assessments, transcranial Doppler measurement of middle cerebral artery flow velocities, or possibly the direct measurement of cerebral blood flow. Monitoring for cerebral well being during carotid occlusion has been discussed in great detail in the medical literature and a recent review of this subject is suggested (94-100).
Conclusion
Glomus tumors are paragangliomas of the head and neck which present challenging anesthetic risks. Clinical manifestations depend on tumor location but most often relate to middle ear and cranial nerve dysfunction. The treatment trend is increasingly surgical, partly because of the increased effectiveness of preoperative imaging and tumor mapping with the CT and 3D-CT scans, magnetic resonance imaging, angiography, and magnetic resonance angiography. Anesthetic risk includes catecholamine secretion, producing symptoms of a pheochromocytoma; serotonin secretion, producing symptoms of carcinoid syndrome; aspiration after tumor resection; impaired gastric emptying; increased intracranial pressure; the threat of venous air embolism; and substantial blood loss. Of the many significant recent developments adding to the understanding of these lesions, the recognition that they may predispose to gastroparesis and new concepts concerning the testing for and treatment of catecholamine and serotonin excess are perhaps most important to the anesthesiologist.
